≡ New Survey Reveals Many Adults With High Cholesterol Fail To Take Necessary Steps To Improve Their Condition Part 4
Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI) today announced that extramural situation from the double-blind, randomized satraplatin Phase 3 enquiry, the SPARC trial (Satraplatin and Prednisone Against Refractory Cancer) be presented today at the 22nd Annual European Association of Urology Congress within Berlin, Germany. The SPARC trial be evaluate satraplatin plus prednisone versus placebo plus […]
